ASO Author Reflections: The value of serum CEA for prognostication at staging and response evaluation in patients with localized pancreatic adenocarcinoma and nonelevated CA19-9 Editorial

   

Authors:	Stoop, T. F.; Doppenberg, D.; Katz, M. H. G.; Tzeng, C. W. D.; Wei, A. C.; Zureikat, A. H.; Groot Koerkamp, B.; Besselink, M. G.; and for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium
Title:	ASO Author Reflections: The value of serum CEA for prognostication at staging and response evaluation in patients with localized pancreatic adenocarcinoma and nonelevated CA19-9
Keywords:	cancer survival; overall survival; cancer patient; pancreatic neoplasms; cancer staging; antineoplastic agent; neoplasm staging; adenocarcinoma; ca 19-9 antigen; carcinoembryonic antigen; pathology; tumor marker; pancreas tumor; pancreas adenocarcinoma; ca-19-9 antigen; survival prediction; cancer prognosis; humans; prognosis; human; article; biomarkers, tumor; antigen blood level
Journal Title:	Annals of Surgical Oncology
Volume:	31
Issue:	3
ISSN:	1068-9265
Publisher:	Springer
Date Published:	2024-03-01
Start Page:	1842
End Page:	1843
Language:	English
DOI:	10.1245/s10434-023-14815-3
PUBMED:	38182848
PROVIDER:	scopus
PMCID:	PMC10838238
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85181445661&doi=10.1245%2fs10434-023-14815-3&partnerID=40&md5=b57630e9193b4da16cc8e1b5eac40146
Notes:	Article -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/213979